In this video, Catherine Lai, MD, MPH discusses the results of a study presented at ASH Annual Meeting that examined time to treatment initiation in patients with acute myeloid leukemia.
Aston Martin Lagonda Global Holdings Plc designs, creates, and exports cars. Its sports cars are manufactured in Gaydon with its luxury DBX SUV range manufactured in St. Athan, Wales. The company ...
Alternatively, some people may receive a hematopoietic stem cell transplant (though less commonly than with AML). Chemotherapy drugs do not penetrate well into the brain and spinal cord due to the ...
The Committee of Experts on the Evaluation of Anti-Money Laundering Measures and the Financing of Terrorism - MONEYVAL is a permanent monitoring body of the Council of Europe entrusted with the task ...
By offering intuitive features and seamless customization, Gamma.app promises to make your presentation journey not only efficient but also enjoyable. Imagine having a virtual assistant that not ...
Ziftomenib, Kura's lead candidate, shows promising results in AML treatment ... Kura hosted a presentation that outlined the terms of the deal. Kura will receive $330 million upon closing ...
Patients with stroke symptoms commonly delay many hours before seeking medical attention. We sought to explore the factors associated with early presentation of stroke patients to physicians. We ...
Background: Acute myeloid leukemia (AML) is a hematologic tumor with poor prognosis and significant clinical heterogeneity. By integrating transcriptomic data, single-cell RNA sequencing data and ...